highperformr logo

Aspect Biosystems's Overview

Total employees109
HeadquartersVancouver
Founded2013

Aspect Biosystems is at the forefront of regenerative medicine, leveraging its proprietary microfluidic 3D bioprinting technology to create living, patient-specific cell therapies. The company focuses on developing treatments for currently incurable diseases by precisely engineering functional human tissues. Their platform technology enables the creation of advanced therapeutics that aim to replace, repair, or regenerate damaged tissues and organs.

Where is Aspect Biosystems's Headquarters?

HQ Function

Serves as the primary center for research and development, bioprocess development, corporate operations, and strategic partnerships. It houses their advanced bioprinting labs and scientific teams.

Notable Features:

State-of-the-art bioprinting laboratories, advanced cell culture facilities, and collaborative research spaces designed to foster innovation in tissue engineering.

Work Culture:

A dynamic and innovative environment driven by a multidisciplinary team of scientists, engineers, and business professionals. The culture emphasizes collaboration, scientific rigor, and a shared passion for developing transformative therapies.

HQ Significance:

The Vancouver headquarters is crucial as it's the birthplace of Aspect's core technology and the central hub for their pioneering work in developing bioprinted therapeutics for global health challenges.

Values Reflected in HQ: The headquarters reflects Aspect's commitment to innovation, cutting-edge science, precision, and its mission to improve patient lives through advanced therapeutic solutions.

Location:

While headquartered in Vancouver, Canada, Aspect Biosystems engages in global collaborations with pharmaceutical companies, academic institutions, and research organizations to advance its bioprinted therapies. Their partnerships (e.g., with Novo Nordisk, J&J Innovation, JDRF) and research efforts have an international scope, aiming to address global health needs. They also present their research at international conferences and engage with a global scientific community.

Street Address:

170 - 887 Great Northern Way

City:

Vancouver

State/Province:

BC

Country:

Canada

Aspect Biosystems's Global Presence

Buying Intent Signals for Aspect Biosystems

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Aspect Biosystems

As of April 2025, Aspect Biosystems' leadership includes:

Tamer Mohamed - Co-founder, President & Chief Executive Officer
Dr. Sam Wadsworth - Chief Scientific Officer
Dr. Lino M. Kim - Chief Business Officer
Dr. Konrad Walus - Co-founder & Chief Technology Officer
Euan Ramsay - Chief Operating Officer
James Taylor - Chief Financial Officer

Investors of Aspect Biosystems

Aspect Biosystems has been backed by several prominent investors over the years, including:

Rhadius Capital
Pangaea Ventures
Pallasite Ventures
Radical Ventures
Relay Ventures
DFJ
Novo Holdings
Brace Pharma Capital
Johnson & Johnson Innovation – JJDC, Inc.

Executive New Hires/Exits in the Last 12 Months

Hire0
Exits0

No major C-suite executive hires or departures have been publicly announced by Aspect Biosystems in the last 12 months (May 2023 - May 2024). The existing leadership team appears stable as they advance their bioprinting platform and therapeutic programs.

Technology (Tech Stack) used by Aspect Biosystems

Discover the tools Aspect Biosystems uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Aspect Biosystems Email Formats and Examples

Aspect Biosystems commonly utilizes the email format combining the first initial of an employee's first name followed by their full last name. Other formats may exist but this is the most frequently observed pattern.

[first_initial][last_name]@aspectbiosystems.com

Format

tmohamed@aspectbiosystems.com

Example

75%

Success rate

News and media

Aspect Biosystems Press ReleaseDecember 5, 2023

Aspect Biosystems Announces Oversubscribed CAD $49M Series B Financing

Aspect Biosystems announced the successful close of an oversubscribed CAD $49 million (approximately USD $36 million) Series B financing round. The funding was led by Rhadius Capital and included participation from new and existing investors such as Pangaea Ventures and Novo Holdings. These funds will be used to advance Aspect's pipeline of bioprinted cell therapies, scale its manufacturing capabilities, and expand its technology platform....more

Aspect Biosystems Press ReleaseMarch 4, 2024

Aspect Biosystems to Present Preclinical Data on Bioprinted Liver Tissue for AATD at EASL Congress 2024

Aspect Biosystems announced it would present new preclinical data on its lead program, a bioprinted liver tissue therapeutic (AB-LVT01) for Alpha-1 Antitrypsin Deficiency (AATD), at the European Association for the Study of the Liver (EASL) Congress 2024. The presentation highlights the potential of their platform to address liver diseases....more

Aspect Biosystems Press ReleaseMay 23, 2023

Aspect Biosystems and JDRF Canada Announce Research Collaboration for Type 1 Diabetes Therapy

Aspect Biosystems and JDRF Canada announced a research collaboration aimed at developing a novel bio-printed therapeutic for type 1 diabetes. The partnership will leverage Aspect's bioprinting technology to create implantable, insulin-producing tissues, with funding support from JDRF Canada....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Aspect Biosystems, are just a search away.